Analytical development
Supporting the formulation development as much as being a full fledge activity in its own right, we offer:
Analytical development and validation
Aerosol particle size distribution (impactors)
ICH stability studies
Dissolution studies
Aptys Pharmaceuticals SAS au capital de 119 220 ¤. R.C.S. Clermont-Fd 444 122 865 - SIRET 444 122 865 00017 - APE 7211 Z - Réalisation Cyberiom
